中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/3181
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1505360      Online Users : 309
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/3181


    Title: Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients
    Authors: 林瑋德(Wei-De Lin);林炫沛;王仲興(Chung-Hsing Wang);胡務亮;莊志光;林秀捐;蔡育勳(Yuhsin Tsai);陳持平(Chih-Ping Chen);蔡輔仁(Fuu-Jen Tsai)*
    Contributors: 中醫學院學士後中醫學系學士班中醫基礎學科;中國附醫醫學研究部遺傳中心
    Keywords: Mucopolysaccharidosis type VI;Arylsulfatase B;Gene mutation;Maroteaux–Lamy syndrome;Lysosomal diseases
    Date: 2008-08
    Issue Date: 2009-08-20 18:04:35 (UTC+8)
    Abstract: Background
    Mucopolysaccharidosis type VI (MPS VI; Maroteaux–Lamy syndrome) is an autosomal recessive lysosomal storage disease induced by a deficiency of the enzyme N-acetylgalactosamine-4-sulfatase (arylsulfatase B, ARSB). The deficiency of ARSB leads to an accumulation of dermatan sulfate (DS) in lysosomes and gross excretion in the urine. The prevalence of these mutations in Asian MPS VI patients has not yet been thoroughly investigated. We studied the ARSB gene profile of 9 Taiwanese MPS VI patients.

    Methods
    To validate the patients' type of MPS, urine mucopolysaccharide was defined by 2-dimensional electrophoresis and leukocyte ARSB activity was determined by fluorogenic assay. Direct sequencing was used to identify any mutation in the patients' ARSB gene.

    Results
    Abnormal excretion of DS and low leukocyte ARSB activity was observed in the urine samples of all 9 patients studied. A total of 8 mutations within the ARSB gene were revealed by molecular analysis. Four mutations, c.574T > C (p.Cys192Arg) and c.943C > T (p.Arg315Stop) mutations had been observed in other populations and c.716A > G (p.Gln239Arg) and c.1197C > G (p.Phe399Leu) were previously reported by our group. The other 4 mutations c.395T > C (p.Leu132Pro), c.908G > A (p.Gly303Glu), c.1228 C > A (p.His430Asn) and c.1394C > G (p.Ser465X), had not been reported before. The c.1197C > G (p.Phe399Leu) and c.395T > C (p.Leu132Pro) mutations were the most common missense mutation in the patients studied (8 in 18 mutant alleles). According to statistical data, the incidence of MPS VI in Taiwan is approximately 1 in 833,000 in live birth.

    Conclusion
    The ARSB gene mutation profile in Taiwanese MPS VI patients may be different from MPS VI patients from other countries.
    Relation: CLINICA CHIMICA ACTA 394(1-2):89~93
    Appears in Collections:[School of Post-Baccalaureate Chinese Medicine] Journal articles

    Files in This Item:

    File SizeFormat
    0KbUnknown527View/Open


    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback